bpc 157 and multiple sclerosis The chronic inflammatory disease is characterized by bpc-157 multiple sclerosis study Pentadecapeptide

Jan 1 2018;24(1):86-105

Crockford, D., et al

Attenuated Gastric Ulcers, Seizures, Brain Lesions, Hepatomegaly, Fatty Liver, Breakdown of Liver Glycogen, Profound Hypoglycemia and Calcification in Rats

By reducing inflammation, TB-500 may contribute to the overall healing process and alleviate discomfort associated with inflammatory conditions

Research Significance The synergy between BPC-157 and TB-500 allows researchers to explore: Accelerated healing models (muscle, tendon, ligament, skin) Cell migration and angiogenesis pathways Anti-inflammatory and protective effects Systemic recovery mechanisms across multiple tissues Specifications Form: Lyophilized peptide powder Content: BPC-157 + TB-500 per vial Storage: Store at -20C